Patents-Review.com
ClassID:

170244 ⎘

G01N2333/085 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus

Sub-classes:
Recent Application in this class:
#1
20240272158
2024-08-15

FECAL SAMPLE TEST METHOD AND IMMUNOCHROMATOGRAPHIC TEST PIECE THEREFOR

 #2
20240272151
2024-08-15

STOOL SPECIMEN TEST METHOD AND IMMUNOCHROMATOGRAPHIC TEST PIECE THEREFOR

 #3
20240230649
2024-07-11

ANTI-NOROVIRUS ANTIBODY

 #4
20240156942
2024-05-16

Peptide of Norovirus Origin, Polynucleotide, Antibody, Composition, Method for Identifying Neutralizing Epitope for Norovirus

 #5
20230366890
2023-11-16

METHOD FOR DETERMINING PRESENCE/ABSENCE OF NOROVIRUS INFECTION RISK

 #6
20230054956
2023-02-23

HUMAN MONOCLONAL ANTIBODIES THAT NEUTRALIZE PANDEMIC GII.4 NOROVIRUSES

 #7
20220289828
2022-09-15

HUMAN MONOCLONAL ANTIBODIES TO ENTEROVIRUS D68

 #8
20220227809
2022-07-21

NOROVIRUS-BINDING PEPTIDE

 #9
20220088098
2022-03-24

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

 #10
20220088097
2022-03-24

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

 #11
20190030027
2019-01-31

Composition and combined medication method for treating enterovirus infection

 #12
20180085411
2018-03-29

Optimized oncolytic viruses and uses thereof

 #13
20180057541
2018-03-01

antigens and methods of use

 #14
20160289678
2016-10-06

USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS

 #15
20160243149
2016-08-25

NOVEL ANTI-VIRAL THERAPEUTIC

 #16
20160216263
2016-07-28

Porcine torque teno virus vaccines and diagnosis

 #17
20150328339
2015-11-19

Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy

 #18
20150056201
2015-02-26

Methods for detecting Th1 cells

 #19
20140348798
2014-11-27

SENECA VALLEY VIRUS BASED COMPOSITIONS AND METHODS FOR TREATING DISEASE

 #20
20130344108
2013-12-26

Inactivated poliovaccine

 #21
20130231466
2013-09-05

Methods for detecting Th1 cells

 #22
20130230523
2013-09-05

Methods for detecting Th1 cells

 #23
20120034676
2012-02-09

Seneca valley virus based compositions and methods for treating disease

 #24
20120027776
2012-02-02

DIABETIC MODEL

 #25
20120003239
2012-01-05

Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)

 #26
20110294986
2011-12-01

Methods For Detecting Th1 Cells

 #27
20110045019
2011-02-24

Porcine torque teno virus vaccines and diagnosis

 #28
20100196874
2010-08-05

METHOD OF DRUG DESIGN

 #29
20100173280
2010-07-08

Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses

 #30
20100129325
2010-05-27

Seneca Valley virus based compositions and methods for treating disease

 #31
20090317796
2009-12-24

Indirect immunofluorescence assay typing kit for coxsackievirus A group and method for typing coxsackievirus A group

 #32
20090275636
2009-11-05

PICORNAVIRUS AND USES THEREOF

 #33
20090087861
2009-04-02

Chimeric tymovirus-like particles and process thereof

 #34
20080248502
2008-10-09

Methods for detecting Th1 cells

 #35
20080102447
2008-05-01

Methods for diagnosing chronic fatigue syndrome

 #36
20070003574
2007-01-04

Picornaviruses, vaccines and diagnostic kits

 #37
20070003573
2007-01-04

Picornaviruses, vaccines and diagnostic kits

 #38
20060246420
2006-11-02

In vitro diagnostic test for enterovirus infections

 #39
20060159659
2006-07-20

Seneca Valley virus based compositions and methods for treating disease

 #40
20060110404
2006-05-25

Set of ubiquitous cellular proteins involved in viral life cycle

 #41
20050277113
2005-12-15

Saliva immunoassay for detection of exposure to infectious agents

 #42
20050260559
2005-11-24

Assay for anti-viral agent

 #43
20050101619
2005-05-12

Anti-picornaviral compounds